Edwards Lifesciences Corp (EW) Habari na Bei za Hisa

(USD)	Jun 2024	Mabadiliko Tangu Mwaka Uliopita
Mapato	1.39B	6.98%
Matumizi ya uendeshaji wa biashara	723.40M	-8.79%
Mapato halisi	366.30M	19.28%
Kiwango cha faida halisi	26.43	11.47%
Mapato kwa kila hisa	0.70	6.06%
EBITDA	416.80M	48.01%
Asilimia ya kodi ya mapato	5.22%	—

Taarifa ya Hali ya Kifedha

Jumla ya mali

Jumla ya dhima

(USD)	Jun 2024	Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi	1.99B	31.84%
Jumla ya mali	10.10B	12.16%
Jumla ya dhima	2.59B	1.45%
Jumla ya hisa	7.50B	—
hisa zilizosalia	602.40M	—
Uwiano wa bei na thamani	5.30	—
Faida inayotokana na mali	9.51%	—
Faida inayotokana mtaji	11.73%	—

Mtiririko wa pesa

Mabadiliko halisi ya pesa taslimu

(USD)	Jun 2024	Mabadiliko Tangu Mwaka Uliopita
Mapato halisi	366.30M	19.28%
Pesa kutokana na shughuli	371.50M	1,005.65%
Pesa kutokana na uwekezaji	124.80M	77.78%
Pesa kutokana na ufadhili	-96.60M	-285.41%
Mabadiliko halisi ya pesa taslimu	429.10M	150.79%
Mtiririko huru wa pesa	283.65M	143.61%

Kuhusu

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia

Ilianzishwa

1958

Makao Makuu

Irvine, California
Marekani

Tovuti

edwards.com

Wafanyakazi

19,800